NVAX logo

Novavax (NVAX) Retained Earnings

Annual Retained Earnings

-$4.82 B
-$545.06 M-12.75%

December 31, 2023


Summary


Performance

NVAX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Quarterly Retained Earnings

-$4.93 B
-$121.30 M-2.52%

September 30, 2024


Summary


Performance

NVAX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

NVAX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.8%-6.1%
3 y3 years-157.2%-36.2%
5 y5 years-271.1%-238.0%

NVAX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-33.3%at low-44.3%+0.8%
5 y5-year-236.7%at low-244.1%+0.8%
alltimeall time<-9999.0%at low<-9999.0%+0.8%

Novavax Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$4.93 B(+2.5%)
Jun 2024
-
-$4.81 B(-3.3%)
Mar 2024
-
-$4.97 B(+3.1%)
Dec 2023
-$4.82 B(+12.7%)
-$4.82 B(+3.8%)
Sep 2023
-
-$4.64 B(+2.9%)
Jun 2023
-
-$4.51 B(-1.3%)
Mar 2023
-
-$4.57 B(+6.9%)
Dec 2022
-$4.28 B(+18.2%)
-$4.28 B(+4.5%)
Sep 2022
-
-$4.09 B(+4.3%)
Jun 2022
-
-$3.93 B(+15.0%)
Mar 2022
-
-$3.41 B(-5.6%)
Dec 2021
-$3.62 B(+93.0%)
-$3.62 B(+30.5%)
Sep 2021
-
-$2.77 B(+13.2%)
Jun 2021
-
-$2.45 B(+16.8%)
Mar 2021
-
-$2.10 B(+11.9%)
Dec 2020
-$1.87 B(+30.9%)
-$1.87 B(+10.5%)
Sep 2020
-
-$1.70 B(+13.2%)
Jun 2020
-
-$1.50 B(+2.9%)
Mar 2020
-
-$1.46 B(+1.8%)
Dec 2019
-$1.43 B(+10.2%)
-$1.43 B(+2.3%)
Sep 2019
-
-$1.40 B(+1.3%)
Jun 2019
-
-$1.38 B(+3.0%)
Mar 2019
-
-$1.34 B(+3.3%)
Dec 2018
-$1.30 B(+16.6%)
-$1.30 B(+3.9%)
Sep 2018
-
-$1.25 B(+3.7%)
Jun 2018
-
-$1.21 B(+3.8%)
Mar 2018
-
-$1.16 B(+4.2%)
Dec 2017
-$1.11 B(+19.8%)
-$1.11 B(+4.8%)
Sep 2017
-
-$1.06 B(+4.4%)
Jun 2017
-
-$1.02 B(+4.6%)
Mar 2017
-
-$974.44 M(+4.8%)
Dec 2016
-$930.00 M(+43.1%)
-$930.00 M(+6.5%)
Sep 2016
-
-$872.89 M(+8.2%)
Jun 2016
-
-$806.63 M(+10.9%)
Mar 2016
-
-$727.28 M(+11.9%)
Dec 2015
-$650.03 M(+31.8%)
-$650.03 M(+13.8%)
Sep 2015
-
-$571.22 M(+6.2%)
Jun 2015
-
-$538.10 M(+4.0%)
Mar 2015
-
-$517.46 M(+4.9%)
Dec 2014
-$493.09 M(+20.2%)
-$493.09 M(+6.8%)
Sep 2014
-
-$461.55 M(+4.5%)
Jun 2014
-
-$441.82 M(+4.2%)
Mar 2014
-
-$423.96 M(+3.4%)
Dec 2013
-$410.15 M(+14.5%)
-$410.15 M(+3.5%)
Sep 2013
-
-$396.09 M(+4.0%)
Jun 2013
-
-$380.79 M(+3.4%)
Mar 2013
-
-$368.16 M(+2.8%)
Dec 2012
-$358.16 M(+8.6%)
-$358.16 M(+2.3%)
Sep 2012
-
-$350.13 M(+2.1%)
Jun 2012
-
-$342.91 M(+1.8%)
Mar 2012
-
-$336.99 M(+2.2%)
Dec 2011
-$329.66 M(+6.2%)
-$329.66 M(+1.1%)
Sep 2011
-
-$325.95 M(+1.0%)
Jun 2011
-
-$322.74 M(+1.6%)
Mar 2011
-
-$317.75 M(+2.4%)
Dec 2010
-$310.29 M
-$310.29 M(+1.6%)
Sep 2010
-
-$305.34 M(+3.5%)
DateAnnualQuarterly
Jun 2010
-
-$294.99 M(+3.3%)
Mar 2010
-
-$285.56 M(+4.0%)
Dec 2009
-$274.58 M(+16.5%)
-$274.58 M(+5.5%)
Sep 2009
-
-$260.19 M(+3.0%)
Jun 2009
-
-$252.66 M(+3.5%)
Mar 2009
-
-$244.13 M(+3.5%)
Dec 2008
-$235.78 M(+18.0%)
-$235.78 M(+4.9%)
Sep 2008
-
-$224.70 M(+3.6%)
Jun 2008
-
-$216.85 M(+4.5%)
Mar 2008
-
-$207.48 M(+3.9%)
Dec 2007
-$199.73 M(+21.1%)
-$199.73 M(+4.8%)
Sep 2007
-
-$190.51 M(+4.9%)
Jun 2007
-
-$181.54 M(+4.7%)
Mar 2007
-
-$173.35 M(+5.1%)
Dec 2006
-$164.96 M(+16.3%)
-$164.96 M(+3.9%)
Sep 2006
-
-$158.81 M(+3.3%)
Jun 2006
-
-$153.80 M(+4.3%)
Mar 2006
-
-$147.39 M(+3.9%)
Dec 2005
-$141.89 M(+8.5%)
-$141.89 M(-4.2%)
Sep 2005
-
-$148.05 M(+1.9%)
Jun 2005
-
-$145.32 M(+4.1%)
Mar 2005
-
-$139.61 M(+6.8%)
Dec 2004
-$130.72 M(+24.7%)
-$130.72 M(+8.5%)
Sep 2004
-
-$120.43 M(+2.3%)
Jun 2004
-
-$117.78 M(+7.0%)
Mar 2004
-
-$110.06 M(+5.0%)
Dec 2003
-$104.80 M(+19.7%)
-$104.80 M(+3.0%)
Sep 2003
-
-$101.72 M(+3.4%)
Jun 2003
-
-$98.36 M(+5.4%)
Mar 2003
-
-$93.33 M(+6.6%)
Dec 2002
-$87.53 M(+35.0%)
-$87.53 M(+6.2%)
Sep 2002
-
-$82.38 M(+8.9%)
Jun 2002
-
-$75.67 M(+7.8%)
Mar 2002
-
-$70.17 M(+8.2%)
Dec 2001
-$64.83 M(+17.7%)
-$64.83 M(+5.2%)
Sep 2001
-
-$61.64 M(+4.2%)
Jun 2001
-
-$59.13 M(+3.2%)
Mar 2001
-
-$57.32 M(+4.1%)
Dec 2000
-$55.09 M(+28.4%)
-$55.09 M(+10.0%)
Sep 2000
-
-$50.10 M(+6.9%)
Jun 2000
-
-$46.88 M(+6.0%)
Mar 2000
-
-$44.24 M(+3.1%)
Dec 1999
-$42.90 M(+11.7%)
-$42.90 M(+2.4%)
Sep 1999
-
-$41.90 M(+4.2%)
Jun 1999
-
-$40.20 M(+2.3%)
Mar 1999
-
-$39.30 M(+2.3%)
Dec 1998
-$38.40 M(+22.7%)
-$38.40 M(+11.3%)
Sep 1998
-
-$34.50 M(+3.6%)
Jun 1998
-
-$33.30 M(+3.4%)
Mar 1998
-
-$32.20 M(+2.9%)
Dec 1997
-$31.30 M(+16.8%)
-$31.30 M(+3.3%)
Sep 1997
-
-$30.30 M(+4.1%)
Jun 1997
-
-$29.10 M(+3.9%)
Mar 1997
-
-$28.00 M(+4.5%)
Dec 1996
-$26.80 M
-$26.80 M(+7.6%)
Sep 1996
-
-$24.90 M(+4.2%)
Jun 1996
-
-$23.90 M(+6.2%)
Mar 1996
-
-$22.50 M

FAQ

  • What is Novavax annual retained earnings?
  • What is the all time high annual retained earnings for Novavax?
  • What is Novavax annual retained earnings year-on-year change?
  • What is Novavax quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Novavax?
  • What is Novavax quarterly retained earnings year-on-year change?

What is Novavax annual retained earnings?

The current annual retained earnings of NVAX is -$4.82 B

What is the all time high annual retained earnings for Novavax?

Novavax all-time high annual retained earnings is -$26.80 M

What is Novavax annual retained earnings year-on-year change?

Over the past year, NVAX annual retained earnings has changed by -$545.06 M (-12.75%)

What is Novavax quarterly retained earnings?

The current quarterly retained earnings of NVAX is -$4.93 B

What is the all time high quarterly retained earnings for Novavax?

Novavax all-time high quarterly retained earnings is -$22.50 M

What is Novavax quarterly retained earnings year-on-year change?

Over the past year, NVAX quarterly retained earnings has changed by -$284.86 M (-6.14%)